InsidersTradesSigma
Total declarations
Companies
▲ Purchases (7 ops.)
▼ Sales (2 ops.)
Insider track record
OtherDisclosed buys
7
Disclosed sells
2
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the detailed record of transactions filed by POPLAR POINT CAPITAL PARTNERS LP. Director active across 2 companies, notably Gyrodyne, LLC. In total, 9 filings have been recorded. Breakdown: 7 buys · 2 sells. Total volume traded: €727k. Activity tracked since 27 August 2021. The latest transaction was filed on 26 March 2025 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations9 total
25,033 shares@ US$0.619924.2% of flowCommon Stock, par value $0.01 per shareSEC:0001398344-25-007139:0
Ideal exit: 22 Nov 2025 (T+270)
14,645 shares@ US$0.5812.8% of flowCommon Stock, par value $0.01 per shareSEC:0001398344-25-007141:0
Ideal exit: 5 Dec 2025 (T+270)
14,000 shares@ US$0.6313.2% of flowCommon Stock, par value $0.01 per shareSEC:0001398344-25-007144:0
Ideal exit: 13 Dec 2025 (T+270)
2,597 shares@ US$0.6352.6% of flowCommon Stock, par value $0.01 per shareSEC:0001398344-25-007136:0
Ideal exit: 31 Oct 2025 (T+270)
31,703 shares@ US$0.6934.1% of flowCommon Stock, par value $0.01 per shareSEC:0001398344-25-007133:0
Ideal exit: 24 Oct 2025 (T+270)
917 shares@ US$0.580.8% of flowCommon Stock, par value $0.01 per shareSEC:0001398344-25-007148:0
Ideal exit: 28 Dec 2025 (T+270)
13,292 shares@ US$0.60912.3% of flowCommon Stock, par value $0.01 per shareSEC:0001398344-25-007146:0
Ideal exit: 21 Dec 2025 (T+270)
30,000 shares@ US$13.0450.0% of flowCommon StockSEC:0001104659-21-111223
30,000 shares@ US$13.042.04% mcap50.0% of flowCommon StockSEC:0001104659-21-111223:0
9 of 9 declarations
About POPLAR POINT CAPITAL PARTNERS LP
POPLAR POINT CAPITAL PARTNERS LP is a declarant with 9 filings in total. Across the 9 sampled filings, the activity runs from 2021-08-30 to 2025-04-15, with EUR 61,231 of buys and EUR 665,509 of sells, and the modal transaction nature is Acquisition. The filings concern NovaBay Pharmaceuticals, Inc. and Gyrodyne, LLC.
